Lead(II)]]>
p. 1−21
2357-0881
Vol.48/No.1
p. 23−52
2357-0881
Vol.48/No.1
512 µg/ml, which is higher than those recommended by CLSI. Seventy-five combined microtitre checkerboards were performed on the five fluroquinolone multiresistant Salmonella strains to assess the potential for combination therapy. No antagonism was observed with any combination. Synergy and additivity were achieved with 41.4% and 58.6%, respectively. Time-kill synergy was more often seen at 24hr. There is 100%, 50% and 40% agreement between time-kill and checkerboard results for three Salmonella strains. Resistant Salmonella has increased in Egypt. Fluroquinolone combination with β-lactams (gentamycin, amikacin) and aminoglycosides (cefotaxime) were effective in the treatment of resistant Salmonella Typhimurium, Enteritidis and Typhi.]]>
p. 53−69
2357-0881
Vol.48/No.1
p. 71−85
2357-0881
Vol.48/No.1